Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy

Cipla slips on the NSE despite USFDA final nod for Albuterol Sulfate Inhalation Aerosol, with plans to launch in H1 FY2026-27 and focus on the US asthma market.